JP2003502308A5 - - Google Patents

Download PDF

Info

Publication number
JP2003502308A5
JP2003502308A5 JP2001503818A JP2001503818A JP2003502308A5 JP 2003502308 A5 JP2003502308 A5 JP 2003502308A5 JP 2001503818 A JP2001503818 A JP 2001503818A JP 2001503818 A JP2001503818 A JP 2001503818A JP 2003502308 A5 JP2003502308 A5 JP 2003502308A5
Authority
JP
Japan
Prior art keywords
aminomethyl
methyl
acid
hexanoic acid
phenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001503818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003502308A (ja
JP3904452B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/015070 external-priority patent/WO2000076958A2/en
Publication of JP2003502308A publication Critical patent/JP2003502308A/ja
Publication of JP2003502308A5 publication Critical patent/JP2003502308A5/ja
Application granted granted Critical
Publication of JP3904452B2 publication Critical patent/JP3904452B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001503818A 1999-06-10 2000-05-31 モノ−およびジ置換3−プロピルガンマ−アミノ酪酸 Expired - Fee Related JP3904452B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13848599P 1999-06-10 1999-06-10
US60/138,485 1999-06-10
PCT/US2000/015070 WO2000076958A2 (en) 1999-06-10 2000-05-31 Mono- and disubstituted 3-propyl gamma-aminobutyric acids

Publications (3)

Publication Number Publication Date
JP2003502308A JP2003502308A (ja) 2003-01-21
JP2003502308A5 true JP2003502308A5 (https=) 2006-01-05
JP3904452B2 JP3904452B2 (ja) 2007-04-11

Family

ID=22482232

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001503818A Expired - Fee Related JP3904452B2 (ja) 1999-06-10 2000-05-31 モノ−およびジ置換3−プロピルガンマ−アミノ酪酸

Country Status (43)

Country Link
EP (1) EP1192125B9 (https=)
JP (1) JP3904452B2 (https=)
KR (1) KR100694735B1 (https=)
CN (2) CN1196671C (https=)
AP (1) AP1397A (https=)
AR (1) AR033335A1 (https=)
AT (1) ATE419231T1 (https=)
AU (1) AU776723C (https=)
BG (1) BG65561B1 (https=)
BR (1) BR0011727A (https=)
CA (2) CA2374755C (https=)
CO (1) CO5200791A1 (https=)
CR (1) CR6529A (https=)
CU (1) CU23101A3 (https=)
CY (1) CY1108827T1 (https=)
CZ (2) CZ301608B6 (https=)
DE (1) DE60041256D1 (https=)
DK (1) DK1192125T3 (https=)
DZ (1) DZ3253A1 (https=)
EA (1) EA004398B1 (https=)
EE (1) EE200100672A (https=)
ES (1) ES2317839T3 (https=)
GE (1) GEP20074142B (https=)
HK (1) HK1046401B (https=)
HR (1) HRP20020025A2 (https=)
HU (1) HUP0201601A3 (https=)
IL (2) IL146969A0 (https=)
IS (1) IS6181A (https=)
MA (1) MA26804A1 (https=)
ME (1) MEP44808A (https=)
MX (1) MXPA01012319A (https=)
NO (2) NO327746B1 (https=)
NZ (1) NZ515668A (https=)
OA (1) OA11962A (https=)
PE (1) PE20010285A1 (https=)
PT (1) PT1192125E (https=)
RS (2) RS50352B (https=)
SI (1) SI1192125T1 (https=)
SK (2) SK287399B6 (https=)
TR (1) TR200103587T2 (https=)
UA (1) UA72519C2 (https=)
WO (1) WO2000076958A2 (https=)
ZA (1) ZA200109711B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164034B2 (en) 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
US6620829B2 (en) 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ATE540678T1 (de) * 2001-06-11 2012-01-15 Xenoport Inc Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
ITMI20011308A1 (it) 2001-06-21 2002-12-21 Nicox Sa Farmaci per il dolore cronico
AU2003201716B2 (en) 2002-01-31 2008-04-17 Warner-Lambert Company Llc Alpha 2 delta ligands to treat tinnitus
NI200300043A (es) 2002-03-28 2003-11-05 Warner Lambert Co AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.
US20030225149A1 (en) 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
US7071339B2 (en) 2002-08-29 2006-07-04 Warner Lambert Company Llc Process for preparing functionalized γ-butyrolactones from mucohalic acid
WO2004054560A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Alpha-2-delta ligand to treat lower urinary tract symptoms
BR0317253A (pt) * 2002-12-13 2005-11-01 Warner Lambert Co Derivados pregabalina para o tratamento da fibromialgia e outras patologias
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
MXPA05006209A (es) * 2002-12-13 2005-08-19 Warner Lambert Co Pregabalina y sus derivados para el tratamiento de fibromialgia y otros trastornos relacionados.
ITMI20022658A1 (it) 2002-12-17 2004-06-18 Nicox Sa Farmaci per il dolore cronico.
WO2005002585A1 (en) * 2003-07-02 2005-01-13 Warner-Lambert Company Llc Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
NZ545494A (en) 2003-09-12 2009-10-30 Pfizer Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
BRPI0414781A (pt) * 2003-09-25 2006-11-21 Warner Lambert Co aminoácidos com afinidade para a proteìna (alfa)2(delta)
EP1670750A1 (en) 2003-09-25 2006-06-21 Warner-Lambert Company LLC Prodrugs of amino acids with affinity for the alpha2delta- protein
WO2006043171A2 (en) * 2004-10-23 2006-04-27 Warner-Lambert Company Llc Methods of using alpha2delta-1 selective compounds
WO2007031263A1 (en) * 2005-09-15 2007-03-22 Ucb Pharma, S.A. 4-substituted pyrr0lidin-2-0nes and their use
US20070141684A1 (en) 2005-12-21 2007-06-21 Pfizer Inc Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
AR061728A1 (es) * 2006-06-30 2008-09-17 Pfizer Prod Inc Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
CA2673545A1 (en) 2006-12-22 2008-07-03 Recordati Ireland Limited Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids
WO2009136375A1 (en) * 2008-05-08 2009-11-12 Pfizer Inc Treatment of interstitial cystitis
EP2509596B1 (en) 2009-12-08 2019-08-28 Case Western Reserve University Gamma aminoacids for treating ocular disorders
CN101914031B (zh) * 2010-07-30 2013-08-28 中国广州分析测试中心 普瑞巴林衍生物及其应用
HUE061437T2 (hu) * 2015-10-23 2023-06-28 Navitor Pharm Inc A Sestrin-GATOR2 kölcsönhatás modulátorai és ezek alkalmazásai
US10912750B2 (en) 2017-04-26 2021-02-09 Navitor Pharmaceuticals, Inc. Modulators of Sestrin-GATOR2 interaction and uses thereof
CN113164414A (zh) 2018-10-24 2021-07-23 纳维托制药有限公司 多晶型化合物和其用途
CA3156436A1 (en) 2019-11-01 2021-05-06 Steven LEVENTER Methods of treatment using an mtorc1 modulator

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
AU9137091A (en) * 1990-11-27 1992-06-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
JP3856816B2 (ja) * 1992-05-20 2006-12-13 ノースウェスターン ユニヴァーシティ 抗発作治療用のgaba及びl−グルタミン酸類縁体
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
IL126999A (en) * 1996-07-24 2002-03-10 Warner Lambert Co Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain
ATE361909T1 (de) * 1996-10-23 2007-06-15 Warner Lambert Co Substituierte gamma-aminobuttersäurederivate als arzneimittel
ATE323067T1 (de) * 1997-10-27 2006-04-15 Warner Lambert Co Zyklische aminosäuren und deren derivate als arzneimittel

Similar Documents

Publication Publication Date Title
JP2003502308A5 (https=)
AU2020203101B9 (en) Tyrosine hydroxylase inhibitors for treating intestinal hyperpermeability
CN1083262C (zh) 左旋-多巴酯类组合物
EP3060200B1 (en) Tyrosine derivatives and compositions comprising them
RU2006125744A (ru) Применение агонистов рецептора сфингозин-1-фосфата (s1p) для лечения дегенеративных заболеваний головного мозга
RU2009145541A (ru) Терапевтические соединения
JP2010526820A (ja) 気分障害、睡眠障害、または注意欠陥障害を治療するドロキシドパおよびその医薬組成物
JP2003532731A5 (https=)
US9757348B2 (en) Composition and methods for treating intestinal hyperpermeability
RU2011129222A (ru) Гемифумаратная соль 1-[4-[1-(4-циклогексил-3-трифторметилбензилоксиимино)этил]-2-этилбензил] азетидин-3-карбоновой кислоты
CA2374755A1 (en) Mono- and disubstituted 3-propyl gamma-aminobutyric acids
JP2010526827A5 (https=)
RU2011147201A (ru) Регероматические и ароматические пиперазинил ацетидинил амиды как моноцилглицероловые ингибиторы липазы
CN1144588C (zh) 睡眠诱发剂
HRP20150526T1 (hr) Supstituirani 2-oksi-kinolin-3-karboksamidi kao modulatori kcnq2/3
WO2012074069A1 (ja) 新規化合物及びその医薬用途
CN1738611A (zh) 用作抗偏头痛剂的α-氨基酰胺衍生物
EP3801546B1 (en) Indole compound for treating interstitial cystitis
CN1646169A (zh) 用于小动物的可注射兽医合成物
JP2020533402A5 (https=)
JP2006511604A5 (https=)
JPH06321774A (ja) 全身麻酔薬とセレギリンを含有する麻酔薬組成物
WO2022184841A1 (en) Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures
Walsh et al. Chemical analgesia for velvet antler removal in deer
CN1649589A (zh) 用艾芬地尔治疗疼痛的方法